The effect of HbA1C variability on the development and progression of diabetic nephropathy
Variability in HbA1c is linked to the onset of DN but not its progression. These findings highlight the need for strategies targeting glycemic stability in DM management. Larger, multicenter prospective studies are warranted to confirm these results.
Authors
- Taner Baştürk (ORCID: https://orcid.org/0000-0003-3371-1207)
- Aslıhan Çalım (ORCID: https://orcid.org/0000-0001-5642-4214)
- Fatih Borlu (ORCID: https://orcid.org/0000-0003-4248-3066)
- Emre Sedar Saygılı (ORCID: https://orcid.org/0000-0003-0022-5704)
- Yüksel Altuntaş (ORCID: https://orcid.org/0000-0002-3559-035X)
- Feyza Yener Öztürk (ORCID: https://orcid.org/0000-0001-5584-4954)
- Yener Koç (ORCID: https://orcid.org/0000-0002-7939-9346)
- Tamer Sakacı
- Alper Coşkun (ORCID: https://orcid.org/0000-0003-2444-6587)
Institutions
- Sağlık Bilimleri Üniversitesi (TR)
- Şişli Etfal Eğitim ve Araştırma Hastanesi (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- Frontiers in Clinical Diabetes and Healthcare
- Published
- 2025-12-01
- DOI
- https://doi.org/10.3389/fcdhc.2025.1718498
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00